Repligen (RGEN) Change in Acquisitions & Divestments (2010 - 2026)

Repligen (RGEN) reported Change in Acquisitions & Divestments of $66.0 million for Q1 2026, up 2300.0% quarter-over-quarter from $2.8 million in Q3 2017.

Repligen (RGEN) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends

Repligen (RGEN) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $66.0 million in Q1 2026.

  • Change in Acquisitions & Divestments for Q1 2026 came in at $66.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $66.0 million (changed N/A YoY), and the FY2023 annual result was $102.3 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments improved to $66.0 million in Q1 2026 per RGEN's latest filing, from $2.8 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $66.0 million in Q1 2026 and troughed at $66.0 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Repligen 7.41 Bn 6.42 Bn 108.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 66.00 Mn
Mar 31, 2026 66.00 Mn
Sep 30, 2017 2.75 Mn
Sep 30, 2017 2.75 Mn
Jun 30, 2017 9.45 Mn
Jun 30, 2017 9.45 Mn
Mar 31, 2017 7.40 Mn
Mar 31, 2017 7.40 Mn
Dec 31, 2016 3.70 Mn
Dec 31, 2016 3.70 Mn
Sep 30, 2016 5.60 Mn
Sep 30, 2016 5.60 Mn
Jun 30, 2016 8.50 Mn
Jun 30, 2016 8.50 Mn
Mar 31, 2016 5.60 Mn
Mar 31, 2016 5.60 Mn
Dec 31, 2015 9.32 Mn
Dec 31, 2015 9.32 Mn
Sep 30, 2015 7.91 Mn
Sep 30, 2015 7.91 Mn